Filing metadata

Accession number
0000950170-24-059747
Form type
Form 3
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
May 14, 2024
Reporting period
May 03, 2024
Description
Initial ownership

Explore SEC Filings Hub